TDI/ Bridge Medicines Seminar

"A Case Study: Drugging Undruggable Targets"
David A. Scheinberg, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center (MSKCC)

"TDI’s Resources for Discovering Breakthrough Drug Candidate(s) for Undruggable Targets"
Michael Foley, Ph.D.
Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI)

"Bridge Medicines’ Skill Set for Developing Drug Candidates into Approved Drug Products"
William Polvino, M.D.
Bridge Medicines

Wednesday, June 21 at 4:00pm to 5:00pm

MSK - Zuckerman Research Center, 105
417 East 68th Street, New York, NY 10065

Event Type

Lecture/Seminar, Translational Lecture/Seminar

Departments

Tri-Institutional Therapeutics Discovery Institute, Meyer Cancer Center

Subscribe
Google Calendar iCal Outlook

Recent Activity